On Friday, Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $1.34 which represents a slight increase of $0.01 or 0.75% from the prior close of $1.33. The stock opened at $1.

SPRINGFIELD – Shelby Electric Cooperative line personnel Dalton Brown, Brian Chevalier and Jamie Sharp emerged as the team ...

Weaver began her career as a loan processor after college and has since built a comprehensive background in mortgage lending.

Bank First (NASDAQ:BFC – Get Free Report) had its price target increased by Piper Sandler from $99.00 to $104.00 in a note issued to investors on Thursday, Marketbeat reports. The firm presently has a ...

In a report released today, Matthew Clark from Piper Sandler maintained a Hold rating on Washington Federal (WAFD – Research Report), ...

We recently compiled a list of the 20 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

In a report released today, Matthew Clark from Piper Sandler maintained a Buy rating on Western Alliance (WAL – Research Report), with a ...

Piper Sandler believes Microsoft (NASDAQ: MSFT)'s upcoming earnings report on October 30 could be "mixed," citing challenges ...

Kevin Nash has always been a charismatic person that many wrestlers loved in real life. However, many hated him too because ...

Jimmy Dunne, the Wall Street deal maker who helped architect the PGA Tour’s controversial deal with the Saudi Arabian Public ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 8.04% of ...

The gross proceeds from the offering are expected to be approximately $75 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Capricor and ...